Abatacept for refractory juvenile idiopathic arthritis-associated uveitis - A case report

Journal of Rheumatology

Volumn 35, Issue 9, 2008, Pages 1897-1898

  Angeles Han, Sheila ^a   Flynn, Thomas ^b   Lehman, Thomas ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b New York Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ADALIMUMAB; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DACLIZUMAB; ETANERCEPT; INFLIXIMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; SALAZOSULFAPYRIDINE; STEROID;

ADOLESCENT; CASE REPORT; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DYSPNEA; EYE INFLAMMATION; FEMALE; HUMAN; IMMUNOGLOBULIN A DEFICIENCY; JUVENILE RHEUMATOID ARTHRITIS; KERATOPLASTY; LETTER; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; TACHYCARDIA; TREATMENT DURATION; UVEITIS; VISUAL ACUITY; VITRECTOMY;

ADOLESCENT; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOCONJUGATES; INFUSIONS, INTRAVENOUS; PREDNISONE; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY;

EID: 54049148255     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)

1. Woreta F, Thorne JE, Jabs DA, Kedhar SR, Dunn JP. Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis (JIA). Am J Ophthalmol 2007;143:647-55.
2. Nakamura S, Yamakawa T, Sugita M, et al. The role of tumor necrosis factor-alpha in the induction of experimental autoimmune uveoretinitis in mice. Invest Ophthalmol Vis Sci 1994;35:3884-9.
3. Sartani G, Silver PB, Rizzo LV, et al. Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming. Invest Ophthalmol Vis Sci 1996;37:2211-8.
4. Vazquez-Cobian LB, Flynn T, Lehman TJA. Adalimumab therapy for childhood uveitis. J Pediatr 2006;149:572-5.
5. Foeldvari I, Nielsen S, Kummerle-Deschner J, et al. Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survery. J Rheumatol 2007;34;1146-50.
6. Genovese MC, Becker JC, Schiff M, et al. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition. N Engl J Med 2005;353:1114-23.
7. Shao H, Woon MD, Nakamura S, et al. Requirement of B7-mediated costimulation in the induction of experimental autoimmune anterior uveitis. Invest Ophthalmol Vis Sci 2001;42:2016-21.
8. Silver PB, Hathcock KS, Chan CC, Wiggert B, Caspi BR. Blockade of costimulation through B7/CD28 inhibits experimental autoimmune uveoretinitis, but does not induce long-term tolerance. J Immunol 2000;165:5041-7.
9. Deschenes J, Char DH, Kaleta S. Activated T lymphocytes in uveitis. Br J Ophthalmol 1988;72:83-7.
10. Wang XC, Norose K, Yano A, Ohta K, Segawa K. Two-color flow cytometric analysis of activated T lymphocytes in aqueous humor of patients with endogenous vs. exogenous uveitis. Curr Eye Res 1995;14:425-33.